Osteoporosis

N Y State Dent J. 2012 Jun-Jul;78(4):30-5.

Abstract

Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes a person to increased risk of fracture. Fractures have severe consequences, so fracture prevention is imperative. Risk factor assessment and bone density testing are important tools in the diagnosis of osteoporosis. Actions to promote strong bones include adequate intakes of calcium and vitamin D; being physically active; not smoking; and avoiding excessive alcohol use. There are several FDA-approved medications for the treatment of osteoporosis. The recent attention to osteonecrosis of the jaw (ONJ) and the association between dental and skeletal health speak to the importance of osteoporosis awareness for dental professionals.

MeSH terms

  • Absorptiometry, Photon
  • Aged
  • Anabolic Agents / therapeutic use
  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use
  • Female
  • Fractures, Bone / etiology
  • Humans
  • Male
  • Middle Aged
  • Oral Health
  • Osteoporosis* / complications
  • Osteoporosis* / drug therapy
  • Osteoporosis* / pathology
  • Teriparatide / therapeutic use

Substances

  • Anabolic Agents
  • Bone Density Conservation Agents
  • Teriparatide